Prevalence and clinical significance of antiphospholipid antibodies in renal transplant recipients

Transplantation

Volumn 67, Issue 1, 1999, Pages 90-93

  Ducloux, Didier ^a   Pellet, Emmanuelle ^a   Fournier, Véronique ^a   Rebibou, Jean Michel ^a   Bresson Vautrin, Catherine ^a   Racadot, Evelyne ^b   Fellmann, Dominique ^c   Chalopin, Jean Marc ^a  

^a HÔPITAL SAINT JACQUES   (France)

^b Blood Transfus Ctr Franche Comte   (France)

^c UNIVERSITÉ DE FRANCHE COMTÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOLIPIN ANTIBODY; PHOSPHOLIPID ANTIBODY;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; DISEASE ACTIVITY; DISEASE ASSOCIATION; FEMALE; HUMAN; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PATIENT CODING; PRIORITY JOURNAL; SEROPREVALENCE; THROMBOSIS;

EID: 0033556559     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199901150-00015     Document Type: Article

References (27)

1. Harris EN, Gharari AE, Boey ML. Anti-cardiolipin antibodies: detection by radioimmunassay and association with thrombosis. Lancet 1983; 2: 12112.
2. Loizou S, McCrea JD, Rudge AC. Measurement of anticardiolipin antibodies by an enzyme-linked immunosorbent assay: standardization and quantitation of results. Clin Exp Immunol 1986; 62: 739.
3. Triplett, DA. Assays for detection of antiphospholipid antibodies. Lupus 1994; 3: 281.
4. Love PE, Santoro SA. Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Ann Int Med 1990; 112: 682.
5. Asherson RA, Khamashta MA, Ordis-Ros J. The primary antiphospholipid syndrome: major clinical and serological features. Medicine (Baltimore) 1989; 68:366.
6. Quereda C, Pardo A, Lamas S, et al. Lupus-like in vitro anticoagulant activity in end-stage renal disease. Nephron 1988; 49: 39.
7. Garcia-Martin F, De Arriba G, Carrascosa T, et al. Anticardiolipin antibodies and lupus anticoagulant in end-stage renal disease. Nephrol Dial Transplant 1991; 6: 543.
8. Sitter T, Spannagl M, Schiffl H. Anticardiolipin antibodies and lupus anticoagulant in patients treated with different methods of renal replacement therapy in comparison to patients with systemic lupus erythematosus. Ann Hematol 1992; 65: 79.
9. Radhakrishnan J, Williams GS, Appel GB, Cohen DJ. Renal transplantation in anticardiolipin antibody-positive lupus erythematosus patients. Am J Kidney Dis 1994; 23: 286.
10. Gronhagen-Riska C, Teppo AM, Helentera A, Honkanen E, Julkunen AE. Raised concentration of antibodies to cardiolipin in patients receiving dialysis. Br Med J 1990; 300: 1696.
11. 2-glycoprotein and anti-prothrombin antibodies in hemodialysis patients. Nephrol Dial Transplant 1997; 12: 2466.
12. Prakash R, Miller CC III, Suki WN. Anticardiolipin antibody in patients on maintenance hemodialysis and its association with recurrent arteriovenous graft thrombosis. Am J Kidney Dis 1995; 26: 347.
13. Vaarala O, Palosuo T, Kleemola M, Aho K. Anticardiolipin response in acute infection. Clin Immunol Immunopathol 1986; 41: 8.
14. Donaldson MC, Weinberg DS, Belkin M, Whitemore AD, Mannick JA. Screening for hypercoagulable states in vascular surgical practice: a preliminary study. J Vasc Surg 1990; 11: 825.
15. Ginsburg KS, Liang MH, Newcomer L, et al. Anticardiolipin antibodies and the risk for ischemic stroke and venous thrombosis. Ann Int Med 1992; 117: 997.
16. Finazzi G, Brancaccio V, Moia M, et al. Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: a four-year prospective study from the Italian registry. Am J Med 1996; 100: 530.
17. Allen RD, Michie CA, Murie JA, Morris PJ. Deep venous thrombosis after renal transplantation. Surg Gynecol Obstet 1987; 164; 137.
18. Cohen H, Neild GH, Mackie IJ, Machin SJ. Persistent decreased fibrinolytic activity in cyclosporin-treated renal allograft recipients. Fibrinolysis 1988; 2: 197.
19. Vanrenterghem Y, Roels L, Lerut T, et al. Thromboembolic complications and haemostatic changes in cyclosporin-treated cadaveric kidney allograft recipients. Lancet 1985; 1: 999.
20. Harris EN, Asherson RA, Hugues GR. Antiphospholipid antibodies: autoantibodies with a difference. Annu Rev Med 1988; 39: 261.
21. Khamashta MA, Harris EN, Gharavi AE, et al. Immune mediated mechanism for thrombosis: antiphospholipid antibody binding to platelet membranes. Ann Rheum Dis 1988; 47: 849.
22. Carreras LO, Defreyn G, Machin SJ, et al. Arterial thrombosis, intrauterine death and the lupus anticoagulant: detection of immunoglobin interfering with prostacyclin formation. Lancet 1981; 1: 244.
23. Ruiz-Arguelles GJ, Ruiz-Arguelles A, Deleze M, Alarcon-Segovia D. Acquired protein C deficiency in a patient with primary antiphospholipid syndrome: relationship to reactivity of anticardiolipin antibody with thrombomodulin. J Rheumatol 1989; 16: 381.
24. Galli, M, Comfurius P, Maassen C. Anticardiolipin antibodies directed not to cardiolipin but to plasma protein factor. Lancet 1990; 335: 1544.
25. McNeil HP, Hunt JE, Krilis SA. New aspects of anticardiolipin antibodies [Editorial]. Clin Exp Rheumatol 1990; 8: 525.
26. Matsuura E, Igarashi Y, Fujimoto M. Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease. Lancet 1990; 336: 177.
27. 2-glycoprotein I antibodies with lupus-type circulation anticoagulant and thrombosis in systemic lupus erythematosus. Am J Med 1992; 93: 223.